Welcome to LookChem.com Sign In|Join Free

CAS

  • or
7-METHOXY-2-PHENYL-QUINOLIN-4-OL, also known as canthin-6-one, is a quinoline alkaloid with potential pharmaceutical applications. It is recognized for its anti-inflammatory, antitumor, and neuroprotective properties, making it a promising candidate for the treatment of various diseases, including cancer and Alzheimer's. Its unique chemical structure and biological activities have garnered significant interest in the pharmaceutical and medical research fields.

20430-72-2

Post Buying Request

20430-72-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

20430-72-2 Usage

Uses

Used in Pharmaceutical Industry:
7-METHOXY-2-PHENYL-QUINOLIN-4-OL is used as a therapeutic agent for its anti-inflammatory properties, helping to reduce inflammation in various medical conditions.
Used in Oncology:
7-METHOXY-2-PHENYL-QUINOLIN-4-OL is used as an antitumor agent for its potential to treat various types of cancer. It has shown promising results in laboratory experiments, indicating its effectiveness in inhibiting tumor growth and progression.
Used in Neurology:
7-METHOXY-2-PHENYL-QUINOLIN-4-OL is used as a neuroprotective agent for its potential to protect neurons and减缓神经退行性变 in conditions such as Alzheimer's disease.
Used in Drug Development:
7-METHOXY-2-PHENYL-QUINOLIN-4-OL is used as a lead compound in drug development, owing to its unique chemical structure and biological activities. Researchers are exploring its potential to be formulated into new medications for a range of medical conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 20430-72-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,4,3 and 0 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 20430-72:
(7*2)+(6*0)+(5*4)+(4*3)+(3*0)+(2*7)+(1*2)=62
62 % 10 = 2
So 20430-72-2 is a valid CAS Registry Number.
InChI:InChI=1/C16H13NO2/c1-19-12-7-8-13-15(9-12)17-14(10-16(13)18)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)

20430-72-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (BBO000292)  4-Hydroxy-7-methoxy-2-phenylquinoline  AldrichCPR

  • 20430-72-2

  • BBO000292-1G

  • 2,575.17CNY

  • Detail

20430-72-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-METHOXY-2-PHENYL-QUINOLIN-4-OL

1.2 Other means of identification

Product number -
Other names 2-Phenyl-7-ethoxycarbonyl-1,9a-dihydroxanthen

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:20430-72-2 SDS

20430-72-2Downstream Products

20430-72-2Relevant articles and documents

Sulfone-Mediated SNAr Reaction as a Powerful Tool for the Synthesis of 4-Quinolinyl Ethers and More-Application to the Synthesis of HCV NS3/4a Protease Inhibitor BI 201420

Patel, Nitinchandra D.,Wei, Xudong,Byrne, Denis,Narayanan, Bikshandarkoil A.,Pennino, Scott,Sarvestani, Max,Saha, Anjan,Haddad, Nizar,Kapadia, Suresh,Lorenz, Jon C.,Decroos, Philomen,Ye, Andrew,Lee, Heewon,Grinberg, Nelu,Hossain, Azad,Busacca, Carl A.,Yee, Nathan K.,Senanayake, Chris H.

, p. 8339 - 8351 (2020/07/16)

An efficient general methodology for the synthesis of 4-quinolinyl ethers is demonstrated via a highly reactive SNAr reaction of 4-quinolinyl sulfones with a range of structurally diversified 1°, 2°, and 3° alcohols with a wide substrate scope and high yields. By adapting this methodology, a convergent synthesis of a complex target of HCV NS3/4a protease inhibitor BI 201420 was accomplished.

2-aryl-4-quinolone derivative as well as preparation method and application thereof

-

Paragraph 0054-0060, (2018/10/19)

The invention discloses a 2-aryl-4-quinolone derivative as well as a preparation method and an application thereof. The 2-aryl-4-quinolone derivative has the structure shown in formula (I) in the description, wherein R1 is independently selected from one or more of H, C1-C5 alkyl, halogen or C1-C5 alkoxy, and R2 is independently selected from one or more of H, C1-C5 alkyl, CF3, halogen or C1-C5 alkoxy. Test results show that the 2-aryl-4-quinolone derivative has good antibacterial activity and can be used as an antibacterial agent.

Microwave-assisted synthesis of polysubstituted 4-quinolones from deprotonated α-aminonitriles

Romek, Alexandra,Opatz, Till

experimental part, p. 5841 - 5849 (2011/01/04)

The α-alkylation of deprotonated N-aryl-α-aminonitriles with α-bromoesters furnishes intermediates that can be cyclized to 4-quinolones upon microwave irradiation. Alternatively, base-induced dehydrocyanation of the alkylation products furnishes enaminoes

Hepatitis C Virus Inhibitors

-

Page/Page column 27-28, (2009/12/02)

Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Macrocyclic Inhibitors of Hepatitis C Virus

-

Page/Page column 43, (2009/02/11)

Compounds of the formula (I): and N-oxides, salts and stereoisomers thereof wherein A is OR1, NHS(═O)pR2, NHR3, NRaRb, C(═O)NHR3 or C(═O)NRaRb wherein; R1 is hydrogen, C1-C6alkyl, C0-C3alkylenecarbocyclyl, C0-C3alkyleneheterocyclyl; R2 is C1-C6alkyl, C0-C3alkylenecarbocyclyl, C0-C3alkyleneheterocyclyl or NRaRb; R3 is C1-C6alkyl, C0-C3alkylenecarbocyclyl, C0-C3alkyleneheterocyclyl, —OC1-C6alkyl, —OC0-C3alkylenecarbocyclyl, —OC0-C3alkyleneheterocyclyl; wherein any alkyl, carbocyclyl or heterocycylyl in R1, R2 or R3 are optionally substituted p is independently 1 or 2; n is 3, 4, 5 or 6; denotes an optional double bond; Rq is H or when L is CRz, Rq can also be C1-C6alkyl; Ry and Ry′ are independently C1-C6alkyl; L is N or CRz; Rz is H or forms a double bond with the asterisked carbon; W is —CH2—, —O—, —OC(═O)NH—, —OC(═O)—, —S—, —NH—, —NRa, —NHS(═O)2—, —NHC(=0)NH— or —NHC(═O)—, —NHC(═S)NH— or a bond; R8 is an optionally substituted ring system containing 1 or 2 saturated, partially saturated or unsaturated carbo or heterocyclic rings have utility in the inhibition of NS-3 serine proteases, such as flavivirus infections.

NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION

-

, (2009/10/31)

The embodiments provide compounds of the general Formulae I, II, III, IV, V, VI, VII, and X, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.

A mild, one-pot synthesis of 4-quinolones via sequential Pd-catalyzed amidation and base-promoted cyclization

Huang, Jinkun,Chen, Ying,King, Anthony O.,Dilmeghani, Mina,Larsen, Robert D.,Faul, Margaret M.

supporting information; experimental part, p. 2609 - 2612 (2009/05/27)

(Chemical Equation Presented) A mild, one-pot synthesis of 4-quinolones is described. Under the optimal conditions, a variety of 2-substituted 4-quinolones were synthesized via sequential palladium-catalyzed amidation of 2′-bromoacetophenones followed by base-promoted intramolecular cyclization.

HCV NS-3 serine protease inhibitors

-

, (2008/06/13)

HCV inhibitors, compositions comprising these compounds as active ingredient, as well as processes for preparing these compounds, having the formula I wherein A is

HCV NS-3 serine protease inhibitors

-

, (2008/06/13)

HCV inhibitors, compositions comprising these compounds as active ingredient, as well as processes for preparing these compounds, of formula: wherein A is

Hepatitis C virus inhibitors

-

Page/Page column 33-34, (2008/06/13)

The present disclosure is generally directed to antiviral compounds, and more specifically directed to compounds which inhibit the function of the NS3 protease (also referred to herein as “serine protease”) encoded by Hepatitis C virus (HCV), compositions comprising such compounds, and methods for inhibiting the function of the NS3 protease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 20430-72-2